Annotated Medicine and Device Lists
| List | Section | Observation |
|---|---|---|
| Organisation of Eastern Caribbean States. Medical Products List. 2019-2021 | 10:00 Anti-neoplastic agents | No observations |
| Barbados. Barbados National Drug Formulary (BNDF) | 10.0 Antineoplastics | No observations |
| List | Section | Observation |
|---|---|---|
| WHO Model List of Essential Medicines (2021) | 8.2.1 Cytotoxic medicines | No observations |
| List | Section | Observation |
|---|---|---|
| Cayman Islands Health Services Authority Pharmacy Drug Formulary | 08.01.04 Vinca Alkaloids and Etoposides | No observations |
| List | Section | Observation |
|---|---|---|
| Haiti. National List of Essential Medicines | 08.02 Cytotoxic and adjuvant drugs | No observations |
| List | Section | Observation |
|---|---|---|
| Ecuador | Essential Medicines List - Ecuador | No observations |
| Trinidad and Tobago. Pharmaceutical Ven Listing 2019. Ministry of Health. | Plant Alkaloids | No observations |
| Jamaica. List of Vital Essential and Necessary Drugs and Medical Sundries for Public Health Institutions. 2015 | 08.04 VINCA ALKALOIDS AND ETOPOSIDE |
Others observations: sulphate |
| Cuba. Cuadro Básico de Medicamentos 2018. Ministerio de Salud Pública. | CUADRO BÁSICO DE MEDICAMENTOS 2018. Ministerio de Salud Pública. |
Others observations: SLN PARA INY O INFUSIÓN IV. |
| Mexico. Cuadro Basico de Medicamentos - 2017 | 17. ONCOLOGIA | No observations |
| Mexico. Cuadro Basico de Medicamentos - 2017 | 17. ONCOLOGIA | No observations |
| Paraguay. Lista de Medicamentos Esenciales. 2009 | 01. ANTINEOPLÁSICOS | No observations |
| El Salvador - 2019 | ANTINEOPLASICOS: Alcaloides de la vinca | No observations |
| Costa Rica. Caja Costarricense de Seguro Social. 2019 | 41. Antineoplásicos y agentes inmunomoduladores | No observations |
| Guyana. Essential Medicines List. 2020-2021 | 0.02.10. Vinca Alkaloids | No observations |
| Suriname. NGK-C-011 | 8.2 Cytotoxic Agents | No observations |
| Haiti. National List of Essential Medicines | 08.02 Cytotoxic and adjuvant drugs | No observations |
| WHO Model List of Essential Medicines (2021) | 8.2.1 Cytotoxic medicines | No observations |
| List | Section | Observation |
|---|---|---|
| Colombia. "Listado de Medicamentos del Plan de Beneficios en Salud con Cargo a la UPC" 2016 | Listado de Medicamentos del Plan de Beneficios en Salud con cargo a la UPC |
Others observations: sulfate INCLUYE TODAS LAS CONCENTRACIONES Y FORMAS FARMACÉUTICAS |
| Argentina. FTN COMRA. Confederacion Medica de la Rep. Argentina. 2018 | 18.01. FÁRMACOS CITOTÓXICOS | No observations |
| List | Section | Observation |
|---|---|---|
| WHO Model List of Essential Medicines (2021) | 8.2.1 Cytotoxic medicines | No observations |
| PAHO Strategic Fund Medicine List | 3.2. Cytotoxic medicines | No observations |
| Peru | 8.2 Cytotoxics | No observations |
| Chile. Formulario Nacional de Medicamentos. 2005 | 07.01. CITOTOXICOS O ANTINEOPLASICOS | No observations |
| Bahamas. Drug Formulary | 10. ANTINEOPLASTIC AND RELATED AGENTS | No observations |
| List | Section | Observation |
|---|---|---|
| WHO Model List of Essential Medicines (2021) | 8.2.1 Cytotoxic medicines | No observations |
| PAHO Strategic Fund Medicine List | 3.2. Cytotoxic medicines |
Others observations: Limited supply options (normally, none or only one supplier identified / prequalified); may result in longer delivery times. |
| Chile. Formulario Nacional de Medicamentos. 2005 | 07.01. CITOTOXICOS O ANTINEOPLASICOS | No observations |